HENRICO DOCTORS HOSPITAL
1. Target Overview & Investment Thesis
HENRICO DOCTORS HOSPITAL is a 686-bed suburban community hospital in HENRICO, VA with $660.5M in net patient revenue and a 18.9% operating margin. The hospital serves a payer mix of 24.9% Medicare, 5.7% Medicaid, and 69.4% commercial.
Thesis: Platform Growth. Our ML models identify $48.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.9% to 26.2% (+736bps).
| Net Revenue HCRIS | $660.5M |
| Current EBITDA COMPUTED | $124.7M |
| Operating Margin COMPUTED | 18.9% |
| Occupancy HCRIS | 41.2% |
| Revenue / Bed COMPUTED | $963K |
| Net-to-Gross HCRIS | 10.6% |
| Distress Probability ML | 50.6% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 18.9% places it above the state median. Among 11 size-comparable peers (343-1372 beds), the median margin is 1.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (343-1372), prioritizing same-state peers. 11 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HENRICO DOCTORS HOSPITAL (Target) | VA | 686 | $660.5M | 18.9% |
| INOVA FAIRFAX HOSPITAL | VA | 860 | $2.41B | 20.5% |
| UNIVERSITY OF VIRGINIA MEDICAL | VA | 665 | $2.37B | 1.1% |
| VCU HEALTH SYSTEM MCV HOSPITAL | VA | 842 | $2.26B | 0.3% |
| CARILION MEDICAL CENTER | VA | 637 | $1.46B | -11.3% |
| SENTARA NORFOLK GENERAL HOSPIT | VA | 472 | $1.34B | 4.9% |
| CJW MEDICAL CENTER | VA | 612 | $1.00B | 32.8% |
| RIVERSIDE REGIONAL MEDICAL CEN | VA | 379 | $963.3M | -20.1% |
| WINCHESTER MEDICAL CENTER | VA | 455 | $694.7M | -5.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $48.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $13.9M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $13.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $13.1M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $8.0M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $423K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $124.7M |
| + RCM Uplift | +$48.6M |
| Pro Forma EBITDA | $173.3M |
| Current Margin | 18.9% |
| Pro Forma Margin | 26.2% |
| WC Released (1x) | $25.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $191.9M | $1.31B | 6.82x | 46.8% |
| Base (11x exit) | 10.0x | 11.0x | $191.9M | $1.50B | 7.83x | 50.9% |
| Bull Case | 9.0x | 11.0x | $172.7M | $1.72B | 9.99x | 58.5% |
| Bull (12x exit) | 9.0x | 12.0x | $172.7M | $1.93B | 11.19x | 62.1% |
| Bear Case | 11.0x | 10.0x | $211.1M | $1.00B | 4.75x | 36.6% |
| Bear (11x exit) | 11.0x | 11.0x | $211.1M | $1.17B | 5.55x | 40.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Elevated distress probability | Model estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 11 hospitals with 343-1372 beds
- Same-state prioritization (n=12)
- Comp margins: P25=-4.3% / P50=1.4% / P75=11.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.